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ABSTRACT Molluscum contagiosum virus (MCV) is a common skin pathogen in 
both adults and children. In this prospective study, we clinically evaluated con-
secutive patients with molluscum contagiosum (MC) who had been examined 
during a 5-year period at the second-largest dermatology clinic in Slovenia and 
described their main demographic and clinical characteristics, concomitant dis-
eases, and treatment success. The study included 188 patients, of which 121 
(64%) were men and 67 (36%) were women. A total of 135 (72%) patients were 
adults, with lesions that were most commonly located in the anogenital region 
(98%) and were probably sexually acquired. Two adult patients were diagnosed 
with concurrent human immunodeficiency virus (HIV) infection. Fifty-three 
(28%) patients were children with a mean age of 5.7 years, most commonly pre-
senting with lesions on the torso and extremities (85%). In adults, the infection 
most commonly occurred in male patients, while in children it was slightly more 
common in female patients. At presentation, 58% of patients had more than 
5 MC lesions. A total of 30% of the included children had concomitant atopic 
dermatitis. We did not observe an increased occurrence of MCV infection in pa-
tients with atopic dermatitis. All patients were treated with curettage of the le-
sions. The cure rate at the first follow-up visit after 2 months was relatively high 
(63%), and recurrences were not associated with the number or site of lesions 
at presentation or with concomitant atopic dermatitis.
KEY WORDS: molluscum contagiosum, sexually transmitted infection, curet-
tage
INTRODUCTION 
Molluscum contagiosum (MC) is a common der-
matologic disease caused by the molluscum conta-
giosum virus (MCV) (1). MCV is a large, brick-shaped, 
double-stranded DNA poxvirus and is the sole mem-
ber of the genus Molluscipoxvirus (2). After eradication 
of smallpox, MCV is the only poxvirus that exclusively 
infects humans (3). MCV is epidermotropic and rep-
licates in the cytoplasm of cells, producing cytoplas-
mic inclusions and enlargement of infected cells (4). 
To date, four subtypes of MCV have been identified 
(5,6). The subtype 1 comprises approximately 76-97% 
of the cases (7,8). The subtype 2 is more prevalent in 
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patients infected with human immunodeficiency vi-
rus (HIV) (9), while subtypes 3 and 4 are relatively rare 
(5,6,9).
Characteristics of patients with mollus-
cum contagiosum
MCV infection is characterized by a single or mul-
tiple flesh-colored umbilicated papules (10). MCV is 
transmitted directly from person to person or by au-
toinoculation (11). MC is relatively frequent in chil-
dren, and although lesions may appear anywhere, in 
children they commonly occur on the face, torso, and 
extremities (12). In adults, MC is regarded as a sexu-
ally transmitted infection (STI), thus all adult patients 
with MC should be carefully screened for other STI 
and appropriately counselled. In adults, MC charac-
teristically involves the genital region, but extrageni-
tal appearance can be more commonly observed in 
persons with immunosuppressive conditions, espe-
cially HIV/AIDS (13). The characteristic umbilicated 
papules develop after an estimated incubation of 
2 weeks to 6 months or longer (11,14). Clinical find-
ings are the most important for establishing the final 
diagnosis. MC is generally self-limited and regresses 
spontaneously after several months or years (15,16). 
However, treatment is recommended and also fre-
quently required by the patient, as it is beneficial in 
preventing further MCV transmission or autoinocu-
lation. Currently, there is no specific treatment for 
MC, and according to the literature, no treatment is 
definitively effective (17). Patients are usually treated 
by physical removal of the lesions by curettage or 
cryotherapy (18,19). Both methods are painful and 
have the potential for scarring and hypopigmenta-
tion. Other physical methods, such as mechanical ex-
pression of the lesion core, electrosurgery, and laser 
therapy, might also be beneficial (20,21).
There are many options for topical treatment 
that have been tried for treating MC. These include 
cantharidin (22), 0.5% podophyllotoxin cream (23), 
imiquimod 5% cream (24,25), potassium hydroxide 
(26,27), and salicylic acid (19). Topical retinoids such 
as tretinoin (0.1 or 0.5 % cream, or 0.025% gel) and 
adapalene have been described as treatment options 
(28,29). Topical phenol (20), silver nitrate 40% paste 
(30), intralesional injections with Candida antigen 
(31), and trichloroacetic acid 70% (32) or iodine (33) 
have also been used for the treatment of MC. System-
ic therapy with oral cimetidine, an H2 antihistamine, 
has been found successful in the treatment of MC in 
one study (34). In HIV-infected patients with refrac-
tory disease, antiretroviral treatment has been as-
sociated with reports of significant improvement of 
MC lesions (35). There are also reports of successful 
treatment of refractory MC in immunocompromised 
patients with topical imiquimod (36-38), systemic or 
intralesional interferon alpha (39-41), parenteral or 
topical cidofovir (42-44), pulsed dye laser, or photo-
dynamic therapy (45,46).
In this prospective study we clinically evaluated 
in detail consecutive patients with MC who had been 
examined during a 5-year period at the second larg-
est dermatology clinic in Slovenia, and described 
their main demographic and clinical characteristics, 
concomitant diseases, and treatment success. To the 
best of our knowledge, this is the largest clinical study 
of MC in Central Europe to date.
PATIENTS AND METHODS
The study included consecutive patients who 
were clinically suspected of MC and were treated at 
the Department of Dermatology and Venereal Dis-
eases at the University Medical Centre (UMC) Maribor, 
Slovenia, from October 2009 to April 2015. The main 
inclusion criterion was lesions that could be clinically 
defined as MC and were located either on the skin, 
torso, or extremities or in the anogenital region. Di-
agnosis was established based on the characteristic 
clinical picture commonly characterized by an umbil-
ical papule of less than 1 cm in diameter. We obtained 
data on patient age, sex, concomitant diseases, site, 
and number of lesions. Patients clinically suspected 
of acquiring MC by a sexual route underwent tests for 
HIV, syphilis, and hepatitis B and C. We photographed 
the lesions using a digital camera before treatment. 
Patients were treated with curettage of all visible 
lesions. If required, lidocaine plus procaine (EMLA 
cream) was applied on the treated spot 1 hour before 
the procedure. At a follow-up visit 2 months after the 
end of treatment the success of treatment or even-
tual recurrence of the disease were assessed.
The study was approved by the Medical Eth-
ics Committee of the Republic of Slovenia (consent 
number: 101/12/09). Written consent was obtained 
from all patients older than 18 years of age and from 
parents of those aged 17 years or less. For categori-
cal variables, statistical analyses were performed with 
the exact test with a Monte Carlo approximation due 
to unbalanced data. A probability of P<0.05 was con-
sidered statistically significant. The data were ana-
lyzed using the statistical software IBM SPSS, version 
22 (SPSS Inc., Chicago, IL, USA).
RESULTS
In the period from October 2009 to April 2015, 
we examined a total of 188 patients with MC lesions, 
of which 121 were men (64%) and 67 were women 
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(36%). Patient age was 0-62 years. Of these, 135 were 
adult patients aged 17 years or older (range 17-62 
years; mean age 27.5 years) who developed MC 
mainly as a result of a sexual/anogenital contact with 
an infected individual, and 53 were children aged 0-
16 years (mean age 5.7 years) who had non-sexually 
transmitted MC lesions (Figure 1, Figure 2). In adults, 
we noticed more male patients (74%), whereas in chil-
dren there were more female patients (60%) (Table 1). 
The difference in the distribution by sex was statisti-
cally significant (P<0.001). 
In adults, lesions were distributed primarily in the 
anogenital region 133/135 (98%), while MC lesions in 
children were most commonly observed on the torso 
and the extremities 45/53 (85%) (Table 2). The differ-
ence in lesion distribution between adults and chil-
dren was statistically significant (P<0.001). 
At examination, 78/135 (58%) of adult patients 
and 32/53 (60%) of children had more than 5 MC le-
sions. The difference in frequency of those with 5 or 
more MC lesions between adults and children was 
not statistically significant (P=0.869).
All adult patients had a larger number of lesions 
(>5) in the anogenital region, whereas in children we 
observed more lesions (>5) on the torso and the ex-
tremities. 
Out of the 53 children included, 16 (30%) pre-
sented with atopic dermatitis. We found more than 
5 lesions in 81% of children with atopic dermatitis 
(n=16), while this was observed in only 52% of chil-
dren without atopic dermatitis. (n=37). However, the 
difference was not statistically significant (P=0.066). 
Two adult patients were diagnosed with an HIV infec-
tion, and four patients also had genital warts.
At presentation, all patients were treated with cu-
rettage and had all visible lesions removed. At the 2-
month follow-up visit, recurrence of MC lesions was 
recorded in 69/188 (37%) patients. The disease re-
curred in 51/135 (38%) of all included adult patients, 
while recurrence was observed in 18/53 (34%) of chil-
dren. There was no statistically significant difference 
with regard to recurrence by age (P=0.737). All re-
currences of MC in adults were observed in the ano-
genital region, whereas in children the disease most 
commonly recurred on the torso and the extremities. 
In adults, MC recurrence was more often observed in 
patients with more than 5 lesions, and the same was 
found in children. However, the difference was not 
statistically significant compared to patients with less 
lesions (P=0.376 and P=0.565, respectively) (Table 3).
Disease recurrence was observed in only 5 out of 
16 children with atopic dermatitis and in 13 out of 
37 children without atopic dermatitis. The difference 
was not statistically significant (P=1.00).
DISCUSSION
Although MC is a relatively frequent disease, there 
is a lack of large published cohort studies in the avail-
able literature, especially from Central and Eastern 
Europe.
This prospective clinical study presents main de-
mographics, lesion localization, concomitant diseas-
es, and results of the most common treatment of the 
Table 1. Study group demographics 
Variable Number of 
patients 
%
All patients 188 100.0
Men 121 64.4
Women 67 35.6
Age >17 years 135 71.8
Age <17 years 53 28.2
Men aged >17 years 100 74.0
Women aged >17 years 35 26.0
Men aged <17 years 21 40.0
Women aged <17 years 32 60.0
Table 2. Distribution of molluscum contagiosum (MC) lesions 
Sites of lesions Torso and extremities Head and neck Anogenital region P
All patients (N=188) 47 4 137
Children (n=53) 45 4 4
<0.001
Adults (n=135) 2 0 133
Figure 1. Penile molluscum contagiosum in a 25-year-old 
man.
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cohort of patients with MC treated at the UMC Mari-
bor in a 5-year period. According to literature data, 
the disease has a bimodal age of onset and most 
commonly occurs in children and young adults (47). 
Although MCV infection more commonly develops in 
children than adults (48,49), we treated more adult 
patients than children at our hospital in the observed 
period. The most probable reason is that children 
with MC in our medical system are usually evaluated 
and treated by school medicine practitioners and 
only fraction is referred to tertiary hospital. The mean 
age of our adult patient was 27.5 years, which is in 
accordance with the literature since MCV infection 
in adults most commonly occurs between 20 and 29 
years of age, similarly as with other sexually transmit-
ted diseases (STD) (11,50). 
The mean age of children included in our study 
who had a non-sexually transmitted MC infection 
was 5.7 years, which is comparable to the results of 
other studies, which found that MC is most com-
mon in children aged 8 years or younger (48). In our 
study, MC was recorded 3 times more commonly in 
adult men than in women patients. This is similar to 
published data, where the authors found that MC 
occurred twice more commonly in the male popula-
tion (51). In our cohort, distribution of the disease in 
children did not differ significantly by sex; however 
there was a slight predominance of female patients. A 
similar distribution by sex was also established in the 
above mentioned study (48). 
Children usually present with multiple MC lesions 
on the face, torso, and extremities. 10-50% of children 
have lesions in the genital region, which is usually a 
result of autoinoculation (52). Very rare non-genital 
lesions in adult patients point to the importance of 
sexual transmission of MCV infections in adults (53), 
whereas non-genital lesions are prevalent in children, 
and lesions in the anogenital region are probably a 
result of autoinoculation (16). In our adult patients, 
MC lesions were most commonly located in the ano-
genital region (98%), while in children they were most 
commonly observed on the torso and extremities 
(58%). Only 7% of all evaluated children had lesions 
in the anogenital region; we strongly believe that this 
is a result of autoinoculation.
At presentation, the majority of adults had more 
than 5 MC lesions. Children had a larger number of le-
sions (>5) on the torso and extremities and less than 
5 lesions on the head or neck and in the anogenital 
region. This leads to the conclusion that parents de-
cide to visit the physician earlier if lesions are located 
on the visible parts (face) or in the anogenital region. 
Adult patients often come to the dermatologist quite 
late, when the infection has already spread. 
According to the literature data, MCV infection 
most commonly occurs in children with atopic der-
matitis (54,55), although this result was contradicted 
by some studies (56). In our study, 30% of children 
with MC also had concomitant atopic dermatitis. Chil-
dren with atopic dermatitis more commonly present-
ed with a larger number of lesions (>5) than children 
without atopic dermatitis, but the difference was not 
statistically significant (P=0.066).
MC is a frequently found in HIV patients (57), with 
prevalence and incidence of the disease reflecting 
advanced immunodeficiency (58). Extragenital distri-
bution of lesions is characteristic in patients infected 
with HIV, with lesions appearing somewhat more 
commonly on the face (59). Two of our patients pre-
sented with HIV infection, and none of them had been 
receiving antiretroviral therapy at the time of pre-
sentation. The HIV-positive male patient had lesions 
located in the pubic region, and the HIV-positive fe-
male patient had them on the abdomen. Incidentally 
identified HIV infection points to the importance of 
testing all adult patients for other STIs, as adult pa-
tients with sexually-transmitted MC lesions are at a 
higher risk of developing other STIs (60). 
Figure 2. Molluscum contagiosum lesions on the inner 
thigh of a 4-year-old boy
Recurrence Adults Children
All patients (N=69) 51 18
Anogenital region 51 2
Trunk and extremities 0 16
Number of lesions (>5) 32 12
Number of lesions (<5) 19 6
Concomitant atopic dermatitis 0 5
Without atopic dermatitis 51 13
Table 3. Comparison between adults and children 
with lesions recurrence at 2-month follow-up visit
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Curettage is the most frequent and effective 
method for removing MC with the least recurrences 
and complications (19). In a previous study, the le-
sions were fully cured in 80% of patients after only 
one treatment (19). Other descriptive studies in the 
literature recorded a lower cure rate, namely 34% (22 
out of 64) and 39% (29 out of 75) (18,61). The num-
ber of lesions, concomitant AD, and the number of 
involved anatomical sites were described as the risk 
factors for treatment failure (18). In our study, the 
cure rate after a single treatment with curettage was 
63% (119/188). At the 2-month follow-up visit, lesion 
recurrence was identified in the rest of the patients 
(69/188, 37%), both adults and children. Considering 
that most adult patients had lesions in the anogenital 
region, recurrences in this site were expected. Some-
what later, recurrences occurred in those patients 
who had a larger number of lesions (>5), but the dif-
ference was not statistically significant. Recurrences 
in children were most commonly observed in those 
who had lesions on the trunk and extremities, as well 
as in those who presented with more than 5 lesions 
at examination. The differences were not statistically 
significant. We did not find a statistically significant 
difference in disease recurrence in children with 
atopic dermatitis as compared to children without 
atopic dermatitis. 
CONCLUSION
In the largest clinical study of MC in Central Eu-
rope to date, MC was more commonly observed in 
adult men compared to adult women, whereas age 
distribution was the reverse in children. Adults in our 
study most commonly presented with MC lesions in 
the anogenital region, whereas in children they were 
most commonly located on the torso and extremities. 
We did not observe an increased occurrence of MCV 
infection in patients with atopic dermatitis. The cure 
rate following treatment with curettage was relative-
ly high (63%), and recurrences were not associated 
with the number of lesions or concomitant atopic 
dermatitis. 
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